Hyperkalaemia Clinical Trials
Conditions / Hyperkalaemia
Delta Trials catalogs 12 clinical trials for Hyperkalaemia in its publicly accessible dataset. Within this set, 2 currently recruiting participants and 8 trials have reached completion. This research occurs across 223 participating sites around the world. An additional 2 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 2 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
12
Total Trials
2
Recruiting
8
Completed
2
Other Active
2
Terminated since 2020
223
Study Locations
Browse by location (223 total)
- Madrid, Spain 4 trialsAll trials in Madrid, Spain
- Beijing, China 3 trialsAll trials in Beijing, China
- Hangzhou, China 3 trialsAll trials in Hangzhou, China
- Hefei, China 3 trialsAll trials in Hefei, China
- Winston-Salem, United States 3 trialsAll trials in Winston-Salem, United States
- Winston-Salem, United States 3 trialsAll trials in Winston-Salem, United States
- Winston-Salem, United States 3 trialsAll trials in Winston-Salem, United States
- Barcelona, Spain 3 trialsAll trials in Barcelona, Spain
- Huelva, Spain 2 trialsAll trials in Huelva, Spain
- Valencia, Spain 2 trialsAll trials in Valencia, Spain
- Changsha, China 2 trialsAll trials in Changsha, China
- Dalian, China 2 trialsAll trials in Dalian, China
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Tianjin, China 2 trialsAll trials in Tianjin, China
- New York, United States 2 trialsAll trials in New York, United States
- Salamanca, Spain 2 trialsAll trials in Salamanca, Spain
- Łódź, Poland 2 trialsAll trials in Łódź, Poland
- Kansas City, United States 2 trialsAll trials in Kansas City, United States